• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Crit Care . The impacts of bacterial co-infections and secondary bacterial infections on patients with severe influenza pneumonitis admitted to th

tetano

Editor, Senior Moderator
J Crit Care


. 2022 Oct 6;72:154164.
doi: 10.1016/j.jcrc.2022.154164. Online ahead of print.
The impacts of bacterial co-infections and secondary bacterial infections on patients with severe influenza pneumonitis admitted to the intensive care units


Wei-Chun Lee[SUP] 1 [/SUP], Meng-Chin Ho[SUP] 1 [/SUP], Shaw-Woei Leu[SUP] 2 [/SUP], Che-Chia Chang[SUP] 1 [/SUP], Chin-Kuo Lin[SUP] 1 [/SUP], Chieh-Mo Lin[SUP] 1 [/SUP], Yu-Hung Fang[SUP] 1 [/SUP], Shu-Yi Huang[SUP] 1 [/SUP], Yu-Ching Lin[SUP] 3 [/SUP], Min-Chun Chuang[SUP] 1 [/SUP], Tsung-Ming Yang[SUP] 1 [/SUP], Ming-Szu Hung[SUP] 3 [/SUP], Yen-Li Chou[SUP] 1 [/SUP], Ying-Huang Tsai[SUP] 4 [/SUP], Meng-Jer Hsieh[SUP] 5 [/SUP]



Affiliations

Abstract

Purposes: This study investigated the prevalence and clinical outcomes of pulmonary bacterial co-infections and secondary bacterial infections in patients with severe influenza pneumonitis.
Methods: We retrospectively analyzed the data of adult patients with severe influenza pneumonitis admitted to medical ICUs. Bacterial co-infections and secondary bacterial infections were identified. The risk factors of bacterial infection were evaluated. The outcomes of patients regarding co-infection or secondary bacterial infection were analyzed.
Results: We identified 117 critically ill patients with laboratory-confirmed influenza pneumonitis admitted to the medical ICUs. Klebsiella pneumoniae (31.4%) and Staphylococcus aureus (22.8%) were the most identified bacteria in patients with bacterial co-infection. A high proportion of methicillin-resistant Staphylococcus aureus (17.1%) was noted. Liver cirrhosis and diabetes mellitus were the independent risk factors for bacterial co-infection. Acinetobacter baumannii (30.7%) and S. aureus (23.1%) were the most often identified bacteria in patients with secondary bacterial pneumonia. Patients with secondary bacterial infections had a longer duration of mechanical ventilation, and longer ICU and hospital stay.
Conclusions: High rates of drug-resistant bacterial co-infections and secondary bacterial infections were identified in patients with severe influenza pneumonitis requiring ICU care and were associated with more morbidity in these patients.

Keywords: Acute respiratory failure; Bacterial co-infection; Bacterial secondary infection; Influenza; Pneumonitis.
 
Back
Top Bottom